Intervention
Mammogram
ClinicalTrials.gov intervention label
Clinical trials
13 shownPrecision Supplemental Imaging in Women With Dense BreastsNCT07277738 · 2026-09-09
RECRUITINGA2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast CancerNCT05989828 · 2024-12-17
RECRUITINGNeoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast CancersNCT05919108 · 2024-06-11
RECRUITINGEarly Detection of Breast Cancer Among Syrian WomenNCT07056686 · 2025-05-17
ENROLLING_BY_INVITATIONTesting Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialNCT06671912 · 2025-02-19
SUSPENDEDSafety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast CancerNCT05547347 · 2023-03-21
SUSPENDEDBreast CANcer Risk Assessment in Younger Women: BCAN-RAYNCT05305963 · 2023-01-31
UNKNOWNMy Personalized Breast ScreeningNCT03672331 · 2019-07-18
ACTIVE_NOT_RECRUITINGPrevention of Obesity-related Cancers: Setting up of a Multi-Cancer Education and Prevention Program in Hong KongNCT04034953 · 2018-08-06
UNKNOWNPilot Study of the Effect of Weight Loss on Breast Tissue and Blood Biomarkers in Women at Increased Risk for Breast CancerNCT02681120 · 2016-10-07
COMPLETEDBreast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation TherapyNCT00925405 · 2009-06-01
TERMINATEDStudy of Breast Tissue in Women Not Previously Diagnosed With Breast Cancer Who Are Undergoing Fine Needle AspirationNCT00896636 · 2009-02-20
UNKNOWNBreast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's DiseaseNCT00165412 · 2005-07-01
COMPLETEDCommon conditions
Breast Cancer5Obesity2Anatomic Stage 0 Breast Cancer AJCC v81Anatomic Stage 1 Breast Cancer AJCC v81Anatomic Stage I Breast Cancer1Anatomic Stage II Breast Cancer1Anatomic Stage IIA Breast Cancer AJCC v81Anatomic Stage III Breast Cancer1Anatomic Stage III Breast Cancer AJCC v81Breast Cancer Detection1Breast Cancer Female1Breast Ductal Carcinoma In Situ1Breast Lobular Carcinoma In Situ1Breast Neoplasms1Breast Screening1Cancer of the Breast1Colorectal Cancer1Estrogen Receptor-Positive Breast Carcinoma1Healthy, no Evidence of Disease1HER2-Negative Breast Carcinoma1Hodgkin's Disease1Invasive Breast Lobular Carcinoma1Locally Advanced Breast Carcinoma1Prostate Cancer1Resectable Breast Carcinoma1
Leading sponsors
Al-Hawash Private University1Alliance for Clinical Trials in Oncology1Chinese University of Hong Kong1Dana-Farber Cancer Institute1M.D. Anderson Cancer Center1Manchester University NHS Foundation Trust1Mayo Clinic1Northwestern University1Tarah J Ballinger, MD1UNICANCER1University of Southern California1Vanderbilt-Ingram Cancer Center1Washington University School of Medicine1
Trial status mix
RECRUITING3
UNKNOWN3
COMPLETED2
SUSPENDED2
ACTIVE_NOT_RECRUITING1
ENROLLING_BY_INVITATION1
TERMINATED1
Phase mix
NA3
PHASE11
PHASE21
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.